Drug Discovery Informatics Market Major Manufacturers, Trends, Demand, Analysis and Forecasts to 2025

Drug Discovery Informatics Market Overview:

In May 2019, Jubilant selected the CDD Vault informatics platform as its discovery research informatics platform for five years
In May, 2019, Dassault Systèmes acquired Medidata Solution adding its clinical expertise and cloud-based solutions to Dassault’s portfolio
In September 2019 Evotec collaborated with Takeda Pharmaceutical Company Limited to establish five drug discovery programs with clinical candidates from Evotec for further clinical development by Takeda across multiple therapy areas

The Drug Discovery Informatics Market is projected to reach USD 3.5 billion in 2025 from USD 2.2 billion in 2020, at a CAGR of 9.3% during the forecast period. Market growth is largely driven by factors such as the rising R&D expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery. However, the scarcity of skilled professionals and the high setup cost of informatics software are expected to limit market growth to a certain extent.

Download PDF:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64537381

The major companies in the drug discovery informatics market include Jubilant Life Sciences Limited (India), Charles River Laboratories (US), IBM (US), Clarivate Analytics (US), and Accenture (Ireland). These players have adopted various growth strategies such as product launches, acquisitions, to increase their presence in the global drug discovery informatics market.

Request For Sample:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=64537381

Segmentation:
By function, the sequencing and target data analysis segment accounted for the largest share for the drug discovery informatics market.
The sequencing and target data analysis segment accounted for the largest share of the drug discovery informatics market for the function segment of the market in 2019. The large share of this segment can be attributed to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains.

By the end-user, the pharmaceutical companies segment accounted for the largest share of the market.
The pharmaceutical companies segment accounted for the largest share of the drug discovery informatics market in 2019; pharmaceutical companies are using this informatics software extensively for pre-clinical research & development, target identification, compound screening and lead identification, and streamlining their drug discovery process which is the major factor for driving the growth of this segment.

By application, the drug development segment accounted for the largest share of the drug discovery informatics market.
The drug development segment accounted for the largest share of the drug discovery informatics market in 2019, large share of this segment is primarily attributed to the increasing investments in the research and development of new drug molecules and the growing need for time and cost optimization for drug discovery and development.

Detailed Information:

https://www.marketsandmarkets.com/Market-Reports/drug-discovery-informatics-market-64537381.html

Key Players:

The major companies in the drug discovery informatics market include Jubilant Life Sciences Limited (India), Charles River Laboratories (US), IBM (US), Clarivate Analytics (US), and Accenture (Ireland).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
sales@marketsandmarkets.com